Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo Tianheng Pharmaceutical, a subsidiary of Fuan Pharmaceutical Group, is a comprehensive pharmaceutical enterprise based in Ningbo, China. The company specializes in the research, development, and large-scale manufacturing of chemical APIs and finished dosage forms, including injections, tablets, and capsules. Its core product portfolio focuses on anti-infectives, digestive system medications, and respiratory treatments, with well-known products like Azithromycin and Famotidine. Tianheng operates state-of-the-art, GMP-certified facilities and is recognized as a national high-tech enterprise. Since its acquisition by Fuan Pharmaceutical Group in 2014, it has served as a critical manufacturing hub for the group's domestic and international market expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical.